Journal Title：Cancer Drug Resistance

Cancer Drug Resistance is an internationally peer-reviewed journal that focuses on the mechanisms of cancer drug resistance and strategies for overcoming them. This magazine is dedicated to publishing original research articles on the basic and translational studies of cancer cells developing tolerance to chemotherapy drugs, including molecular mechanisms, cell signaling pathways, drug design, and clinical treatment. The content of the magazine not only covers the resistance of traditional chemotherapy, but also the resistance mechanisms against targeted therapy and immunotherapy.

This journal provides a platform for the cancer research community to discuss the latest research findings, treatment strategies, and clinical trial results, with a particular focus on emerging treatment methods and technologies, such as the application of nanomedicine in improving drug efficacy and overcoming drug resistance. The magazine has promoted the scientific community's understanding of the complexity of cancer drug resistance and accelerated the development of new treatment methods by publishing high-quality research papers.

《癌癥藥物耐藥性》是一本專注于癌癥藥物抵抗機(jī)制及其克服策略的國(guó)際同行評(píng)審期刊。該雜志致力于發(fā)表關(guān)于癌癥細(xì)胞對(duì)化療藥物產(chǎn)生耐受性的基礎(chǔ)和轉(zhuǎn)化研究，包括分子機(jī)制、細(xì)胞信號(hào)通路、藥物設(shè)計(jì)和臨床治療等方面的原創(chuàng)研究文章。雜志的內(nèi)容不僅涵蓋了傳統(tǒng)化學(xué)療法的耐藥性，還包括針對(duì)靶向治療和免疫治療的抵抗機(jī)制。

該期刊為癌癥研究社區(qū)提供了一個(gè)討論最新研究發(fā)現(xiàn)、治療策略和臨床試驗(yàn)結(jié)果的平臺(tái)，特別關(guān)注新興的治療方法和技術(shù)，如納米醫(yī)學(xué)在提高藥物療效和克服耐藥性方面的應(yīng)用。雜志通過發(fā)表高質(zhì)量的研究論文，促進(jìn)了科學(xué)界對(duì)癌癥藥物抵抗復(fù)雜性的理解，并加速了新治療方法的開發(fā)。

Cancer Drug Resistance由OAE Publishing Inc.出版商出版，收稿方向涵蓋ONCOLOGY全領(lǐng)域，平均審稿速度 ，影響因子指數(shù)4.6，該期刊近期沒有被列入國(guó)際期刊預(yù)警名單，廣大學(xué)者值得一試。